title: [Antiphospholipid syndrome (Hughes syndrome): 10 years of study in Russia].
authors.forename: E L
authors.initials: EL
authors.lastname: Nasonov
authors.forename: Z S
authors.initials: ZS
authors.lastname: Alekberova
authors.forename: L A
authors.initials: LA
authors.lastname: Kalashnikova
authors.forename: T M
authors.initials: TM
authors.lastname: Reshetniak
authors.forename: E N
authors.initials: EN
authors.lastname: Aleksandrova
mesh_terms: D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000276:immunology; D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D012189:Retrospective Studies; D012426:Russia / Q000453:epidemiology
chemical_list: D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D000970:Antineoplastic Agents; D005938:Glucocorticoids; D007074:Immunoglobulin G; D010975:Platelet Aggregation Inhibitors